• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by 51job Inc.

    3/29/22 9:00:16 AM ET
    $JOBS
    Diversified Commercial Services
    Technology
    Get the next $JOBS alert in real time by email
    6-K 1 tm2120623d10_6k.htm FORM 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of March 2022

     

    Commission File Number: 000-50841

     

    51job, Inc.

    (Translation of registrant’s name into English)

     

    Building 3

    No. 1387 Zhang Dong Road

    Shanghai 201203

    People’s Republic of China

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

     

     

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      51JOB, INC.
       
      By:   /s/ Rick Yan
        Name: Rick Yan
        Title: President and Chief Executive Officer

     

    Date: March 29, 2022

     

     

     

     

    EXHIBIT INDEX

     

    ExhibitDescription
      
    99.1Press release regarding the convening of an extraordinary general meeting of shareholders of 51job, Inc. dated March 29, 2022

     

     

     

    Get the next $JOBS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JOBS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JOBS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services
    • Shareholders of YS Biopharma Announce an Extraordinary General Meeting

      BEIJING, Feb. 8, 2024 /PRNewswire/ -- Shareholders of YS Biopharma Co., Ltd. (NASDAQ:YS) ("YS Biopharma"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced they are convening an extraordinary general meeting of shareholders ("EGM"). The shareholders convening the meeting (the "Convening Shareholders") include Yi Zhang, the founder of YS Biopharma and a director, who (as of February 8, 2024) beneficially owns approximately 52% of the issued and outstanding ordinary shares of YS Biopharma through the acting-in-concert arrangement. The

      2/8/24 6:10:00 PM ET
      $YS
      $JOBS
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Diversified Commercial Services
      Technology
    • 51job, Inc. Announces Completion of Merger

      SHANGHAI, May 6, 2022  /PRNewswire/ -- 51job, Inc. (Nasdaq: JOBS) ("51job" or the "Company"), a leading provider of integrated human resource services in China, announced today the completion of the merger (the "Merger") with Garnet Faith Limited, an exempted Company with limited liability incorporated under the laws of the Cayman Islands ("Merger Sub"), pursuant to the previously announced agreement and plan of merger, dated as of June 21, 2021, as amended by amendment No. 1 to agreement and plan of merger, dated as of March 1, 2022 (the "Merger Agreement"), between the Company and Merger Sub, and the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands

      5/6/22 4:10:00 PM ET
      $JOBS
      Diversified Commercial Services
      Technology